Perspectives on Precision Oncology Issue 4

In this review:

Another year is nearly over. It feels like only a few weeks ago that we (in the UK, anyway) were saying good riddance to 2020, and hoping for a COVID respite in 2021. We haven’t yet seen that, as the Delta variant has wreaked havoc everywhere. At least things are starting to look up for NZ, with both enviable vaccination rates and a stabilising infection rate. As you prepare for a well-deserved summer break, we are taking the opportunity to wind up the year with a few final papers and a look forward to what we hope 2022 will bring.

Please login below to download this issue (PDF)